AKEEGA: payments to doctors
Payments that named AKEEGA as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $2.7M
- Providers
- 7,212
- Transactions
- 18,599
- Average per transaction
- $146
The per-transaction average — $146 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 7,212 providers the average total is $377, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Johnson & Johnson | $2,664,129 | 98.0% |
| Janssen Scientific Affairs, LLC | $54,780 | 2.0% |
| Janssen Global Services, LLC | $731 | 0.0% |
| Janssen Research & Development, LLC | $34 | 0.0% |